✦ LIBER ✦

Achievement of Diabetes-Related Treatment Goals with Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)

✍ Scribed by Woo, Vincent; Blonde, Lawrence; Mathieu, Chantal; Yee, Jacqueline; Vijapurkar, Ujjwala; Meininger, Gary

Book ID: 127042737
Publisher: Canadian Diabetes Association
Year: 2014
Tongue: English
Weight: 162 KB
Volume: 38
Category: Article
ISSN: 1499-2671
DOI: 10.1016/j.jcjd.2014.07.161

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lower Blood Pressure (BP) with Canaglifl

Lower Blood Pressure (BP) with Canagliflozin (CANA) in Subjects with Type 2 Diabetes Mellitus (T2DM)

✍ Gilbert, Richard E.; Weir, Matthew; Januszewicz, Andrzej; González, Fernando Lav 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 51 KB

Efficacy and Safety of Canagliflozin (CA

Efficacy and Safety of Canagliflozin (CANA) in Older Subjects with Type 2 Diabetes Mellitus (T2DM)

✍ Harris, Stewart; Sinclair, Alan; Bode, Bruce; Vijapurkar, Ujjwala; Gassmann-Maye 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 155 KB

Efficacy of Canagliflozin (CANA) in Pati

Efficacy of Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM) by Baseline Body Mass Index (BMI)

✍ Leiter, Lawrence A.; Blonde, Lawrence; Wilding, John; Cerdas, Sonia; Tong, Cindy 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 74 KB

Efficacy and Safety of Canagliflozin (CA

Efficacy and Safety of Canagliflozin (CANA) Across a Range of Treatment Paradigms Used in Patients with Type 2 Diabetes Mellitus (T2DM)

✍ Bajaj, Harpreet S.; Miller, Eden; Roussel, Ronan; Davies, Michael; Meininger, Ga 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 72 KB

Long-Term Efficacy and Safety of Canagli

Long-Term Efficacy and Safety of Canagliflozin (CANA) in Older Patients with Type 2 Diabetes Mellitus (T2DM) Over 104 Weeks

✍ Harris, Stewart; Bode, Bruce; Stenlöf, Kaj; Sullivan, Daniel; Fung, Albert; Usis 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 47 KB

Effect of Canagliflozin (CANA) in Patien

Effect of Canagliflozin (CANA) in Patients With Type 2 Diabetes Mellitus (T2DM) Based on Age and Estimated Glomerular Filtration Rate (eGFR)

✍ Gilbert, Richard; Weir, Matthew R.; Fioretto, Paola; Law, Gordon; Usiskin, Keith 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 158 KB